Dosisjusteringer, monitorering og seponering Dosisjustering foretages for at nå et terapeutisk vindue (mitotanplasmaniveau mellem 14 og 20 mg/ l), hvilket sikrer optimal anvendelse af Lysodren med acceptabel sikkerhed.
Dose adjustments, monitoring and discontinuation Dose adjustment is aimed to reach a therapeutic window (mitotane plasma levels between 14 and 20 mg/ l) which ensures optimal use of Lysodren with acceptable safety.